ப்ராக் நட்டில் அறிவியல் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராக் நட்டில் அறிவியல் ஒன்றுபட்டது மாநிலங்களில். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராக் நட்டில் அறிவியல் ஒன்றுபட்டது மாநிலங்களில் Today - Breaking & Trending Today

Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy


Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy
Pratteln, Switzerland, April 28, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen Biopharma announce new clinical data of 2.5-year treatment outcome with vamorolone in patients with Duchenne muscular dystrophy (DMD). These Phase 2a long-term treatment data demonstrate
a maintenance of treatment effect, equivalent to a delay of about two years in decline for
time to stand (TTSTAND) velocity, and confirm safety and tolerability benefits of vamorolone over the 2.5-year follow up period.
Long-term treatment with vamorolone resulted in significantly fewer corticosteroid-associated adverse events than reported in other clinical trials with other steroids. ....

Switzerland General , United States , United Kingdom , Eric Hoffman , Eva Kalias , Reveragen Biopharma , Dario Eklund , Reveragen Biopharma Inc , Santhera Pharmaceuticals , International Neuromuscular Research Group , National Institutes Of Health , Muscular Dystrophy Association United States , Head External Communications , European Commission Horizon , Duchenne Research Fund , Foundation To Eradicate Duchenne , Santhera Pharmaceuticals Holding , European Commission Horizons , Chiesi Group , Us Department Of Defense , Us National Institutes Of Health , Reveragen Announce New , Treatment Data , Duchenne Muscular Dystrophy , These Phase , History Study ,